DUBLIN, July 4, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026" report to their offering.
Primary brain and central nervous system (CNS) tumours (ICD-10 codes C70-C72) are a group of primary tumours arising in the brain, meninges or central nervous system. As such, this is a cluster of conditions rather than one disease per se. There are considered to be over 120 types of brain tumour including glioblastoma multiforme (GBM), meningiomas and astrocytomas.
This report provides the current incident population for Brain & CNS Cancer across 19 Major Markets (USA, France, Germany, Italy, Spain, UK, Turkey, Russia, India, Canada, Australia, Japan, China, South Korea, Argentina, Brazil, Mexico, South Africa and Saudi Arabia) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Brain & CNS Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Brain & CNS Cancer include:
- Genetic susceptibility
- Family history of brain & CNS cancers
- Ionizing radiation exposure
- Non-ionizing radiation exposure (e.g. mobile phones, electromagnetic fields)
- Growth hormone deficiencies
- Epilepsy & seizures
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key Co-morbid Conditions Associated with the Disease
8. Methodology for Quantification of Patient Numbers
9. Top-Line Brain & CNS Cancer Incidence
10. Location and Histopathology of Brain & CNS Cancer
- Location of Brain & CNS Cancer
- Histopathology of Neuroepithelial Brain & CNS Cancer
- Glioblastoma Multiforme and Other Types of Glial Brain & CNS Cancer
11. Abbreviations and Acronyms used in the Report
12. Patient-Based Offering
13. Online Pricing Data and Platforms
14. References
15. Appendix
For more information visit http://www.researchandmarkets.com/research/5dz8gc/brain_and_cns
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
